CIK 0001574094
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271448452
- Phone
- +1 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-10 | VOLL MARK Chief Financial Officer | Grant or award | +80,000 | 222,380 | ||
| 2026-05-19 | VOLL MARK Chief Financial Officer | Purchase | +25,000 | $0.79 | $20K | 142,380 |
| 2026-04-03 | VOLL MARK Chief Financial Officer | Grant or award | +80,000 | 117,380 | ||
| 2026-03-25 | VOLL MARK Chief Financial Officer | Grant or award | +12,380 | 37,380 | ||
| 2026-03-20 | VOLL MARK Chief Financial Officer | Purchase | +97,200 | 97,200 | ||
| 2026-03-20 | VOLL MARK Chief Financial Officer | Purchase · Warrants | +48,600 | 48,600 |
Page 1 of 1 · 6 trades